Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...

Germany’s Merck KGaA has agreed to acquire U.S. biotech SpringWorks Therapeutics for $3.9 billion. The acquisition, aimed at ...

Sullivan & Cromwell is acting for longtime client Merck in its $3.9bn acquisition of US biotech company SpringWorks ...

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

President Donald Trump has stoked tensions between the U.S. and Europe with his tariff-fueled trade war, and alarmed European ...

Caterpillar said Wednesday it anticipates that tariffs may increase its second-quarter costs by up to $350 million as its ...

Recent developments in health highlight key agreements between countries, drug approvals, corporate revenue growth, and ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Summit Therapeutics (SMMT – Research Report) and Altimmune (ALT – Research Rep ...

The U.S. economy shrank at a 0.3% annual pace from January through March, first drop in three years. It was slowed by a surge ...

New Britain-based toolmaker Stanley Black & Decker raised prices in April in response to tariffs, and it is planning another ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

The official survey by the China Federation of Logistics and Purchasing shows export orders slowed in April, with Beijing and ...